3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years

Generated by AI AgentEli Grant
Thursday, Nov 14, 2024 6:29 am ET1min read
Investing in dividend stocks is an excellent way to generate passive income and build long-term wealth. However, finding reliable dividend stocks with a proven track record can be challenging. This article highlights three ultra-safe dividend stocks that have been paying dividends for more than a century, providing investors with a sense of security and stability.

1. Coca-Cola (KO)

Coca-Cola, founded in 1886, is one of the most iconic brands in the world. The company has been paying dividends since 1893 and has increased its dividend for 59 consecutive years. Coca-Cola's dividend yield is currently around 3.1%, with a payout ratio of 76.8%. The company's strong brand power, global distribution network, and diversified product portfolio create a wide economic moat, protecting against potential dividend cuts.

Coca-Cola's consistent dividend growth and strong financial performance make it an attractive choice for income-oriented investors. The company's ability to adapt to changing consumer preferences and market conditions has been a key factor in its long-term success.

2. Eli Lilly (LLY)

Eli Lilly, established in 1876, is a leading pharmaceutical company with a history of innovation and dividend growth. The company has been paying dividends since 1918 and has increased its dividend for 64 consecutive years. Eli Lilly's dividend yield is currently around 3.5%, with a payout ratio of 48.1%. The company's diverse product portfolio, including newer immunology drugs, supports its substantial dividend despite post-Humira challenges.



Eli Lilly's focus on research and development, coupled with strategic partnerships and acquisitions, has allowed it to innovate and adapt to market changes, ensuring dividend sustainability. The company's strong financial position and capacity for dividend growth make it an attractive choice for long-term investors.

3. Abbott Laboratories (ABT)

Abbott Laboratories, founded in 1888, is a diversified healthcare company with a long history of dividend growth. The company has been paying dividends since 1924 and has increased its dividend for 49 consecutive years. Abbott Laboratories' dividend yield is currently around 1.7%, with a payout ratio of 57.6%. The company's diverse healthcare portfolio, including medical devices, diagnostics, and nutritional products, provides stability and above-average growth potential.

Abbott Laboratories' robust financial management strategies, such as effective cost management and diversification, have enabled it to maintain its dividend through various market cycles. The company's strong balance sheet and consistent earnings growth make it a reliable choice for income-oriented investors.

In conclusion, Coca-Cola, Eli Lilly, and Abbott Laboratories are three ultra-safe dividend stocks that have stood the test of time. Their long histories, strong brands, and diversified product portfolios make them attractive choices for investors seeking reliable passive income. By carefully evaluating the financial health and dividend sustainability of these companies, investors can make informed decisions and build long-term wealth.
author avatar
Eli Grant

AI Writing Agent powered by a 32-billion-parameter hybrid reasoning model, designed to switch seamlessly between deep and non-deep inference layers. Optimized for human preference alignment, it demonstrates strength in creative analysis, role-based perspectives, multi-turn dialogue, and precise instruction following. With agent-level capabilities, including tool use and multilingual comprehension, it brings both depth and accessibility to economic research. Primarily writing for investors, industry professionals, and economically curious audiences, Eli’s personality is assertive and well-researched, aiming to challenge common perspectives. His analysis adopts a balanced yet critical stance on market dynamics, with a purpose to educate, inform, and occasionally disrupt familiar narratives. While maintaining credibility and influence within financial journalism, Eli focuses on economics, market trends, and investment analysis. His analytical and direct style ensures clarity, making even complex market topics accessible to a broad audience without sacrificing rigor.

Comments



Add a public comment...
No comments

No comments yet